Disclosed are methods for marking a pharmaceutical product, container or pharmaceutical packaging system with a scent to establish the identity and/or source of the pharmaceutical.
대표청구항▼
1. A method for providing for the identification of a pharmaceutical dosage form comprising: imparting a volatile scent or scent profile to a pharmaceutical dosage form comprising an active agent during manufacture of the dosage form, which scent or scent profile in the dosage form is of a type and
1. A method for providing for the identification of a pharmaceutical dosage form comprising: imparting a volatile scent or scent profile to a pharmaceutical dosage form comprising an active agent during manufacture of the dosage form, which scent or scent profile in the dosage form is of a type and in an amount that is physiologically unperceivable by humans but is detectable by a non-human animal or an electronic olfactory measuring device; andassociating the scent or scent profile with the identity of the dosage form;wherein the dosage form is a tablet or a capsule,the scent or scent profile being imparted is not already associated with the dosage form and indicates when and/or where the pharmaceutical dosage form was manufactured, bottled or packaged, andthe presence of the scent or scent profile indicates that the dosage form is authentic. 2. A method for providing for the identification of a pharmaceutical dosage form comprising: selecting a pharmaceutical dosage form containing an active ingredient that has been approved by a governmental agency for distribution and sale to the public;imparting a volatile scent or scent profile useful to determine the identity or source of the dosage form to the dosage form during manufacture of the dosage form in an amount that does not require re-approval by the governmental agency of the dosage form reformulated to include the scent or scent profile; which scent or scent profile is of a type and in an amount in the dosage form that is physiologically unperceivable by humans but is detectable by a non-human animal or an electronic olfactory measuring device; andassociating the scent or scent profile with the identity or source of the dosage form;wherein the dosage form is a tablet or a capsule, andthe scent or scent profile being imparted is not already associated with the dosage form, and the presence of the scent or scent profile indicates that the dosage form is authentic. 3. The method of claim 1, wherein the scent or scent profile is detectably varied between different batches of the dosage form so as to enable the ability to distinguish between the different batches of the dosage form using a non-human animal or an electronic olfactory measuring device. 4. The method of claim 1, wherein the dosage form comprises an opioid analgesic. 5. The method of claim 2, wherein the scent or scent profile is detectably varied between different batches of the dosage form so as to permit distinguishing between the different batches of the dosage form using a non-human animal or an electronic olfactory measuring device. 6. The method of claim 2, wherein the dosage form comprises an opioid analgesic. 7. A method for providing for the identification of a pharmaceutical dosage form comprising: imparting a volatile scent or scent profile useful to determine the identity or source of the dosage form to a pharmaceutical dosage form comprising an active agent during manufacture of the dosage form, which scent or scent profile is in an amount or concentration which (i) is below the human olfactory threshold of the scent or scent profile and (ii) is detectable by a non-human animal or an electronic olfactory measuring device,wherein the dosage form is a tablet or a capsule,the scent or scent profile being imparted is not already associated with the dosage form, and the presence of the scent or scent profile indicates that the dosage form is authentic. 8. The method of claim 7, further comprising the step of associating the scent or scent profile with the identity or source of the dosage form. 9. A method for providing for the identification of a pharmaceutical dosage form, comprising: imparting a volatile scent or scent profile useful to determine the identity or source of the dosage form to a pharmaceutical dosage form comprising an active agent during manufacture of the dosage form, which scent or scent profile is in an amount or concentration that is physiologically is detectable by a non-human animal or an electronic olfactory measuring device, andallowing for an authentication of the dosage form by associating the scent or scent profile with the source of the dosage form,wherein the dosage form is a tablet or a capsule,the scent or scent profile being imparted is not already associated with the dosage form, and the presence of the scent or scent profile indicates that the dosage form is authentic. 10. The method of claim 9, wherein the dosage form comprises an opioid analgesic. 11. The method of claim 7, wherein the dosage form comprises an opioid analgesic. 12. The method of claim 1, wherein the scent or scent profile being imparted is not already associated with the dosage form. 13. The method of claim 2, wherein the scent or scent profile being imparted is not already associated with the dosage form. 14. The method of claim 7, wherein the scent or scent profile being imparted is not already associated with the dosage form. 15. The method of claim 9, wherein the scent or scent profile being imparted is not already associated with the dosage form. 16. The method of any one of claims 1, 2, 3, 4, 5-7, 8, 9, 10, and 11-15 wherein the tablet is a sustained release tablet. 17. The method of claim 16, wherein the scent is in a coating of the dosage form. 18. The method of any of claims 1, 2, 3, 4, 5-7, 8, 9, 10, and 11-15 wherein the scent is in a sequestered form. 19. The method of claim 1, wherein the dosage form has been approved by a governmental agency for distribution and sale to the public. 20. The method of claim 1, wherein the dosage form has been approved by a government agency for distribution and sale to the public. 21. The method of claim 7, wherein the dosage form has been approved by a governmental agency for distribution and sale to the public. 22. The method of claim 9, wherein the dosage form has been approved by a governmental agency for distribution and sale to the public. 23. The method of claim 1, wherein the dosage form is free from perfluorocarbon tracers. 24. The method of claim 1, wherein the scent or scent profile allows for determination of manufacturing date or a batch number of the dosage form. 25. The method of claim 2, wherein the scent or scent profile allows for determination of manufacturing date or a batch number of the dosage form. 26. The method of claim 7, wherein the scent or scent profile allows for determination of manufacturing date or a batch number of the dosage form. 27. The method of claim 7, wherein the scent or scent profile allows for determination of manufacturing date or a batch number of the dosage form.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (50)
Clawson Burrell E. ; Weigl James, Apparatus to distinguish containers.
Garner Ronald C. (Sand Hutton GB3) Martin Carl N. (Thorganby GB3) Wraith Michael J. (Sittingbourne GB3) Britton David W. (Faversham GB3), Marking of products to establish identity and source.
Garner Ronald Colin,GB3 ; Phillips David J. ; Wilkinson Timothy G.,GB3 ; Angella Frank G. ; Dorland Erwin R.,GB3 ; Stow Martin W.,GB3, Marking of products to establish identity and source.
Sato Takaaki (Amagasaki JPX) Hirono Junzo (Amagasaki JPX), Method and apparatus for discriminating chemical/physical quantity based on the transient response.
Masson Claudine J. C. (295 rue Saint Jacques 75005 Paris FRX) Thal Marie-Florence O. J. (15ter rue des Clos Saint-Marcel 92330 Sceaux FRX), Method for marking an object to enable its detection from a distance in the event of loss or theft.
Balestrieri Giorgio (New York NY) Kaish Norman (Whitestone NY), Method of tagging and detecting drugs, crops, chemical compounds and currency with perfluorocarbon tracers (PFT\S).
Voss Harald (Bad Homburg DEX) Rothweiler Herbert (Rheinfelden-Eichsel DEX), Pharmaceutical compositions with analgesic properties and the preparation and use thereof.
Marino ; Jr. Michael A. (Marlton NJ) Gordon ; Jr. John L. (Yardville NJ) St. Hilaire Richard J. (Cherry Hill NJ), Sealed label having anti-counterfeit construction.
Cuca Robert C. (Edwardsville IL) Harland Ronald S. (Chesterfield MO) Riley ; Jr. Thomas C. (Manchester MO) Lagoviyer Yury (St. Louis MO) Levinson R. Saul (Chesterfield MO), Tastemasked pharmaceutical materials.
Gordon Virginia C. ; Sorensen John T. ; Mirhashemi Soheila ; Mittelstein Michael ; Elias John F., Test kits for determining at least two specific analytes in foods and other complex matrices.
Suzuki Akira (Shibukawa JPX) Ishida Akira (Harahigashi JPX) Oya Masao (Tokyo JPX), Vinylidene chloride copolymer as a material for production of packaging articles.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.